TrialCell reports. Medicine2025

Toripalimab, bevacizumab, and irinotecan in dMMR/MSI locally advanced colorectal cancer: First-stage results from a phase 1b/2 trial.

Zhenghang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.